Chicago Capital Management’s Vigil Neuroscience VIGL Stock Holding History

Chicago Capital Management’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-482,769	Closed	-$3.84M	–	41
2025 Q2	$3.84M	Buy	+482,769	New	+$2.16M	2.82%	13

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Chicago Capital Management's VIGL Position: Q3 2025 in Review

Chicago Capital Management sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 482,769 shares — an estimated $3.84M sold.

Chicago Capital Management first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $3.84M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Chicago Capital Management reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Chicago Capital Management sold 482,769 Vigil Neuroscience shares in Q3 2025, an estimated $3.84M.
Chicago Capital Management first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
Chicago Capital Management's Vigil Neuroscience position peaked at $3.84M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Chicago Capital Management's 13F filing for Q3 2025, filed 7 Nov 2025.